Pradeep Nathan is neuroscientist with over 15 years experience in drug discovery and development in the area of Psychiatry and Neurology. He has held senior roles at GSK, UCB Pharma, Lundbeck, and Sosei Heptares and was involved in the translational development of over 20 targets in neuroscience from pre-clinical to Phase 3 clinical development. He is currently Vice President, Clinical Development at Cybin Inc. Pradeep is also an Honorary Professor at King's College London. He has published over 200 papers in the area of experimental medicine, cognitive and affective neuroscience.